How to File a claim for Celebrex injuryWritten by Jefferson Highway, General Counsel
There is mounting evidence to suggest that Celebrex (aka celecoxib) is linked to an increased risk of blood clots, heart attacks and strokes. Celebrex is one of newer anti arthritic drugs called COX-2 inhibitors that were launched in 1990s, and is marketed by Pharmacia Corporation and Pfizer Inc. The drug is prescribed for osteoarthritis, adult rheumatoid arthritis, and menstrual cramps. The FDA is currently taking independent advice on whether these COX-2 inhibitors, and Celebrex in particular, are safe to remain on sale. Current studies "strongly suggest" COX-2 inhibitors increase risk of cardiovascular problems, says Dr. Ned Braunstein, senior director of Merck Research Laboratories. A related study from Cleveland Clinic, published in Journal of American Medical Association suggested that risk of cardiovascular problems (including but not limited to heart attacks, chest pains, stroke, death and blood clots), was over twice as high in rofecoxib sample than in control group - a significant find given that analysis was based on more than 8,000 patients. In yet another study of over 42,000 participants, 0.52% of patients taking a placebo pill had a heart attack each year compared to 0.74% for patients taking rofecoxib and 0.80% for those taking celecoxib. It's big business too - drug will do over $6 billion this year alone.